Coulter Partners

The countdown is on for #BioShares2026! Our colleague Michael Huberts is looking forward to seeing you at the 20th annual BioShares Biotech Summit, in Queenstown, New Zealand, on August 6-7. As the premier gathering for emerging ASX-listed life science companies, the summit provides an exceptional platform to go beyond typical investor presentations and explore the true drivers of commercial growth. In an increasingly competitive global market, unlocking the full value of groundbreaking science requires the right leadership and board structures at every stage of scale. If you are attending and would like to discuss your talent strategy, board composition, or executive search needs across the APAC region, Michael would love to connect. Reach out to him directly to schedule a meeting in Queenstown! #bioshares2026 #biosharessummit #lifescience #networking #APAC

Recruitment fraud is increasing globally, with scammers impersonating executive search firms, consultants, and legitimate career opportunities across email, LinkedIn, WhatsApp, SMS, and other platforms. As an AESC Member Firm, we are joining a coordinated awareness effort to help clients and candidates recognize suspicious outreach and better understand what legitimate executive search communication should look like. A real executive search process should be professional, transparent, and verifiable. Candidates should never be asked to pay to be considered for a role, submitted to a client, coached for an opportunity, or introduced to a hiring organization. Check Before You Connect. Verify the sender. Confirm the firm. Protect yourself. Learn more: https://lnkd.in/gpa-Mtpe #CheckBeforeYouConnect #RecruitmentFraud #ExecutiveSearch #WeAreAESC

12 episodes of The Next Quarter podcast 🎙️ From inflatable incubators saving lives in neonatal wards to re-engineering how patients navigate fragmented healthcare systems – our journey exploring the future of health, tech, and bio has officially hit a dozen episodes. Led by our Client Partner, Ian Coyne, the series continues to dive deep with the pioneers who are bridging the gap between groundbreaking discovery and real-world delivery. If you’re catching up, our latest two episodes represent the exact kind of frontier leadership we love to spotlight: ▪️ Episode 11: James Roberts MBE, Founder & CEO of mOm Incubators. James shares the incredible journey of designing a compact, cost-effective incubator to prevent vulnerable baby deaths globally – and what it takes to turn a student prototype into a life-saving medical device. 👉 Listen here: https://lnkd.in/eJ2is5mi ▪️ Episode 12: Michelle Carnahan, CEO & Co-founder at Arbiter. With our CEO Nicholas Green co-hosting, Michelle draws on her leadership at Eli Lilly and Sanofi to explain why the next massive wave of healthcare innovation isn't about discovering new drugs – it's about delivering them to the patients who need them. 👉 Listen here: https://lnkd.in/eimhPdRU (And yes, we still ask every pioneer what their seven-year-old self would think of their current job title!) Missed the first ten? Find the full library featuring leaders from Hertility, Angelini Ventures, Perci Health, and more: https://lnkd.in/e74ZrGrF #TheNextQuarter #HealthTech #Innovation #Leadership #CoulterPartners #Podcast #DigitalHealth #MedTech #VentureCapital

Coulter Partners successfully led a search for Salvia BioElectronics and is pleased to announce the placement of Jill Schiaparelli, MBA, as Chair of its Board of Directors. Salvia BioElectronics is a clinical-stage medical device company pioneering a neuromodulation therapy for people with debilitating migraine. Its MySalvia neuromodulation platform is poised to set a new standard of care and restore quality of life to hundreds of millions of people who suffer with resistant migraine, a condition in which significant disability persists despite multiple treatments. Hubert Martens, Founder and CEO of Salvia, said: “Our collaboration with Coulter Partners was vital to this search. Navigating a transatlantic placement within a highly technical and niche clinical sector requires deep domain expertise. The Coulter Partners team demonstrated impressive international reach and real strategic agility, acting as a seamless extension of our business to secure a world-class U.S. leader who shares our vision to deliver drug-free relief to millions of migraine sufferers.” Penny Sadler, Managing Partner at Coulter Partners, said: “Identifying a Chair in the niche neuromodulation medical device market in the U.S. is particularly challenging given the complex market dynamics and limited talent pool of leaders who combine venture-backed CEO experience, deep commercial expertise, and a proven ability to scale within a highly specialized and evolving segment. Our goal was to uncover an executive who could translate pioneering science into an impactful U.S. commercial strategy, and Jill’s phenomenal track record of taking breakthrough bioelectronic platforms from inception through to regulatory milestones makes her uniquely positioned to guide Salvia through its next growth inflection point.” Nona Footz, Client Partner at Coulter Partners, added: “Jill is the unique combination of deep technical experience coupled with high EQ, a leadership track record of making an impact in growing companies, and leveraging her knowledge and network to help drive team performance. Her innate understanding of operational scale-up within the American healthcare ecosystem, paired with her extensive board-level governance experience, ensures that Salvia is remarkably well-positioned. It was a privilege to partner with Hubert and the Salvia Board to complete this high-impact international placement.” Read the full press release here: https://lnkd.in/e3i7rQSK    #Innovation #TeamBuilding #ExecutiveSearch #Leadership #TopTalent #Health Key players for this placement: Nona Footz, Penny Sadler, Laura Esam, Rachel Matos, Fiona Ferri, Lucy Webb and Andrea Litovszky 

Coulter Partners recently co-hosted its annual London Tech Week Super Connector event at Hale House in London. As part of London Tech Week, the Health & Tech Collective brought together over 300 investors, founders, and ecosystem leaders. Led and presented on the day by our very own Managing Partner, Ian Coyne, the focus was simple: bridging the capital, capability, and customer gaps to accelerate healthcare innovation. 🎬Watch the highlights below to see the energy from 2.5 hours of pure, uninterrupted networking (and a huge congratulations again to the THENA Capital team on the close of their £45m Fund I!). If you ended up on our waitlist this time, do not worry - we will be doing this all over again at the end of the year. A huge thank you to the incredible co-hosts and partners across the Collective who made this possible: Molly Gilmartin and Lucia Rodriguez Lacasa at AlbionVC Hakim Yadi Ph.D. OBE at Baringa Ian Coyne at Coulter Partners Sophie McGrath at Goodwin Dr. Rayna Patel and Dr Lucinda Scharff at Google Dominick Kennerson at HSBC Innovation Banking Tatum Getty at THENA Capital Jack Porter and Mindy Simon at NHS Innovation Accelerator Jessica Somauroo at SomX #LondonTechWeek #HealthTech #Innovation #VentureCapital #TalentStrategy #CoulterPartners

Coulter Partners successfully led a search for Cellcolabs and is pleased to announce the placement of Vincent Metzler, Ph.D., as Chief Executive Officer (CEO). Cellcolabs is a Swedish biotechnology company specializing in the large-scale, industrial production of high-quality mesenchymal stromal cells (MSCs) to prevent and treat debilitating and life-threatening diseases. Maria Rankka, Chair of Cellcolabs, commented: “Partnering with Coulter Partners was essential to securing a leader of Vincent’s caliber. Their specialized international network and deep understanding of the advanced therapies landscape allowed them to identify an executive who perfectly combines a sophisticated scientific foundation with the commercial and fundraising track record needed to drive our regenerative medicine platform forward.” Sabine Moravi, Associate Partner at Coulter Partners, added: “Cellcolabs is at an extraordinary inflection point, blending world-leading stem cell science with true industrial production capabilities. Finding a leader who could steer this transition required a rare mix of cell therapy expertise, strategic partnership experience, and a proven history of scaling international biopharma organizations. Vincent is an exceptional fit. His specialized expertise in cell therapy commercialization and corporate fundraising, notably demonstrated during his tenure at Kither Biotech and Atara Biotherapeutics, makes him uniquely qualified to lead Cellcolabs through this next high-growth chapter.” Read the full press release here: https://lnkd.in/eA2rHjtd #Innovation #TeamBuilding #ExecutiveSearch #Leadership #TopTalent #Health Key players for this placement: Sabine Moravi, Kay Wardle PhD, Charlotte Visholm, Hafsah Bhatti, Ruby Charteris

That's a wrap on a brilliant HLTH Europe week in Amsterdam! Coulter Partners loved co-organizing the Health Tech Mixer to kick off the festivities with our ecosystem partners, and the energy carried right through the main event. Read Managing Partner Ian Coyne's full post below for a breakdown of the major themes driving the Health Tech conversation this week, from market reality checks to emerging data momentum.

Coulter Partners successfully led a search for Cancer Research Horizons and is pleased to announce the placements of Heather Preston, Richard Wooster and Hans Bishop as Non-Executive Directors (NEDs) to its Board. Cancer Research Horizons is the innovation arm of Cancer Research UK. Its strategy focuses on working directly with researchers to help them maximize the impact of their work, providing funding, expertise and advice to translate research out of the lab and into tools, tests and treatments that benefit people with cancer.   The new board members bring extensive biotech business, scientific and fund-raising experience to help accelerate the translation of scientific discoveries into patient benefit.  Iain Foulkes, CEO of Cancer Research Horizons, commented: “We chose to work with Coulter Partners because of the depth of their networks and their understanding of the type of people we need to future-proof our organization. Their ability to simultaneously source three distinct leadership profiles and shepherd us through the process of bringing them on board ensured that we have the right mix of clinical, scientific, and entrepreneurial rigor to drive our mission forward”. Dr. Justine McIlroy, Client Partner at Coulter Partners, added: “We are proud to have worked with Cancer Research Horizons on these critical Board appointments. Delivering a multi-track international search required a highly collaborative effort across our firm. Working alongside my colleagues Laura Esam and Dr. Kay Wardle, we managed a carefully choreographed board succession process, with the goal of bringing CRH a mix of business leadership, translational science and venture fundraising experience. Heather’s investment acumen, Richard’s world-class scientific pedigree and Hans’s entrepreneurial track record will be instrumental in helping CRH bridge the gap between academic innovation and market-ready cancer therapies.” Read the full press release here: https://lnkd.in/ezJYFehB #Innovation #TeamBuilding #ExecutiveSearch #Leadership #TopTalent #Health Key players for this placement: Justine McIlroy, Kay Wardle PhD, Laura Esam, Bianca Coulter, Hafsah Bhatti, Gemma Nash, Victoria Claro MSc, Melanie Craven, Fiona Ferri

Are you at HLTH Europe in Amsterdam this week? So is our colleague Ian Coyne! As Europe’s premier platform for health innovation, HLTH brings together the brightest minds across digital health, biopharma, and healthcare delivery to tackle the industry’s most complex challenges. In a rapidly evolving ecosystem, scaling a healthtech or digital health business requires a distinct blend of agile leadership, commercial excellence, and technological expertise. Ian is looking forward to discussing the talent strategies, board dynamics, and executive leadership trends that are currently de-risking investments and accelerating growth across the continent. If you are attending and would like to explore how to build the leadership teams needed to reach your next milestone, please reach out to them directly to arrange a coffee. #HLTHEurope #HealthInnovation #DigitalHealth #HealthTech #ExecutiveSearch #TalentStrategy #Leadership #CoulterPartners

Our colleague Sabine Moravi will be attending the Austrian Life Science Day on 16th June in Vienna! Organized by LISAvienna and ecoplus, this year’s edition is hyper-focused on a critical pillar of innovation: clinical evidence to support the development of drugs and medical devices. If you are attending and want to discuss your talent strategy, leadership milestones, or how to attract top-tier operators to your ecosystem, please reach out to Sabine. You can arrange a meeting with her directly via LinkedIn or through the online partnering system. hashtag #ALSD2026 #biotech #innovation #networking #conference